• Search
  • Helpdesk
  • Sales contact

Oncology Case Study

Last updated: April 29, 2025

Oncology studies present specific challenges that generate complex eCOA build and management: complex study design, frequent amendments, and long study duration that can affect patient engagement and site organization.

To overcome these challenges, Kayentis offers strong and global experience in complex oncology trials, especially with:

  • experienced teams and strong processes to face trial complexities and amendments,
  • a large set of data collection modes for an optimal data entry,
  • additional features for the comfort of the patient,
  • and functionalities adapted to support site staff,

Kayentis contributes to the success and quality of oncology clinical trials.

Learn more in the case study 👇

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

The critical importance of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies – Webinar

July 9 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET
In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....

DPHARM 2025

SEPT 16-17 2025 • Philadelphia, PA, USA
Booth #44 16th Annual Outsourcing in Clinical Trials East Coast 2025 - Arena International

SCDM 2025

Baltimore, Maryland, USA - 27-30 SEPT 2025
Annual Conference 2025 – SCDMLive    

SCOPE Europe 2025

OCT 14-15 2025 • Barcelona, Spain
SCOPE Europe | Summit for Clinical Operations Executives | October 14-15, 2025 |Barcelona, Spain